Combining CES Alpha-Stim and InterX for Optimized Rehabilitation Following Extremity Immobilization

Completed · Not applicable · Has a placebo group

Conditions studied: Neuropathic Pain

In brief

This study will be aimed at assessing the feasibility of a dual-device treatment prior to a rehabilitation session for an orthopaedic injury requiring immobilization, and its impact on improving outcomes and decreasing the risk for development of neuropathic pain. The investigators will evaluate the clinical feasibility and effectiveness of incorporating the Alpha-Stim and Inter-X treatment into a standard rehabilitation protocol to address risk factors associated with the development of neuropathic pain (i.e., pain, range of motion, and skin temperature) as well as its impact on reduced pain medication.

Key facts

Study ID
NCT03060122
Run by
Brooke Army Medical Center
People needed
35
Starts
2018-03-01
Expected to finish
2019-08-07
Last updated by the study team
2019-11-25

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.